Exagen (XGN) Competitors $6.99 -0.01 (-0.14%) Closing price 04:00 PM EasternExtended Trading$7.02 +0.04 (+0.50%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XGN vs. CSTL, PSNL, INNV, EHAB, SBC, CELC, AUNA, TALK, OMDA, and FTREShould you be buying Exagen stock or one of its competitors? The main competitors of Exagen include Castle Biosciences (CSTL), Personalis (PSNL), InnovAge (INNV), Enhabit (EHAB), SBC Medical Group (SBC), Celcuity (CELC), Auna (AUNA), Talkspace (TALK), Omada Health (OMDA), and Fortrea (FTRE). These companies are all part of the "healthcare" industry. Exagen vs. Its Competitors Castle Biosciences Personalis InnovAge Enhabit SBC Medical Group Celcuity Auna Talkspace Omada Health Fortrea Exagen (NASDAQ:XGN) and Castle Biosciences (NASDAQ:CSTL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability. Is XGN or CSTL more profitable? Castle Biosciences has a net margin of -1.46% compared to Exagen's net margin of -27.34%. Castle Biosciences' return on equity of 3.41% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-27.34% -133.69% -34.87% Castle Biosciences -1.46%3.41%2.95% Does the media prefer XGN or CSTL? In the previous week, Castle Biosciences had 2 more articles in the media than Exagen. MarketBeat recorded 3 mentions for Castle Biosciences and 1 mentions for Exagen. Exagen's average media sentiment score of 1.89 beat Castle Biosciences' score of 1.76 indicating that Exagen is being referred to more favorably in the media. Company Overall Sentiment Exagen Very Positive Castle Biosciences Very Positive Do analysts prefer XGN or CSTL? Exagen currently has a consensus target price of $7.50, suggesting a potential upside of 7.30%. Castle Biosciences has a consensus target price of $37.00, suggesting a potential upside of 88.20%. Given Castle Biosciences' higher possible upside, analysts clearly believe Castle Biosciences is more favorable than Exagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Castle Biosciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, XGN or CSTL? Exagen has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Comparatively, Castle Biosciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Which has stronger valuation & earnings, XGN or CSTL? Castle Biosciences has higher revenue and earnings than Exagen. Castle Biosciences is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$55.64M2.68-$15.11M-$0.84-8.32Castle Biosciences$332.07M1.71$18.25M-$0.19-103.47 Do insiders & institutionals hold more shares of XGN or CSTL? 75.3% of Exagen shares are held by institutional investors. Comparatively, 92.6% of Castle Biosciences shares are held by institutional investors. 12.6% of Exagen shares are held by company insiders. Comparatively, 6.5% of Castle Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryCastle Biosciences beats Exagen on 10 of the 15 factors compared between the two stocks. Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XGN vs. The Competition Export to ExcelMetricExagenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$149.10M$10.60B$5.61B$9.11BDividend YieldN/A2.07%5.24%4.01%P/E Ratio-8.3216.2727.9620.25Price / Sales2.6830.15430.8999.65Price / CashN/A22.9637.4658.16Price / Book12.943.668.045.49Net Income-$15.11M$235.43M$3.18B$250.27M7 Day Performance3.79%1.27%3.72%4.78%1 Month Performance-3.72%1.79%3.72%7.20%1 Year Performance261.24%-14.57%29.92%17.27% Exagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XGNExagen3.3141 of 5 stars$6.99-0.1%$7.50+7.3%+276.3%$149.10M$55.64M-8.32220CSTLCastle Biosciences2.3463 of 5 stars$20.42+0.3%$37.00+81.2%+13.5%$587.55M$332.07M-107.47540Positive NewsPSNLPersonalis3.4884 of 5 stars$6.56-0.3%$7.67+16.9%+346.5%$581.18M$85.69M-5.09400News CoverageINNVInnovAge0.9967 of 5 stars$3.69-5.9%$5.00+35.5%-16.2%$529.25M$763.85M-16.042,350News CoverageGap DownEHABEnhabit2.5127 of 5 stars$9.64+0.8%$8.75-9.2%-14.2%$484.09M$1.03B-3.4810,700SBCSBC Medical GroupN/A$4.64flatN/AN/A$480.76M$205.42M0.00N/AHigh Trading VolumeCELCCelcuity2.2969 of 5 stars$13.35+6.5%$30.80+130.7%-19.2%$474.84MN/A-4.4140Positive NewsAUNAAuna3.2608 of 5 stars$6.20-2.2%$10.70+72.6%-19.2%$469.24M$1.17B10.6914,842High Trading VolumeTALKTalkspace3.9329 of 5 stars$2.78+0.4%$4.50+61.9%+36.8%$463.46M$187.59M139.07500News CoverageOMDAOmada HealthN/A$18.30+3.9%N/AN/A$453.46MN/A0.00849Analyst ForecastQuiet Period ExpirationFTREFortrea3.8355 of 5 stars$4.94-0.8%$15.00+203.6%-77.6%$450.69M$2.70B-0.5615,500Trending NewsAnalyst ForecastGap Down Related Companies and Tools Related Companies CSTL Alternatives PSNL Alternatives INNV Alternatives EHAB Alternatives SBC Alternatives CELC Alternatives AUNA Alternatives TALK Alternatives OMDA Alternatives FTRE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XGN) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
